The Company
RetroVirox is an innovative, privately-held biotechnology company dedicated to discovering new treatments for patients with infectious diseases.
The company is focused on developing approaches to treat or cure infectious diseases, including the development of immunomodulators for HIV eradication and antivirals for the treatment of hemorrhagic arenaviruses such as Lassa Fever virus. RetroVirox was founded with an initial investment by scientists and entrepreneurs to translate into cures research previously funded by the National Institutes of Health (NIH).
RetroVirox offers its expertise in antiviral assays and cell-based screening for antiviral compounds to other biotechnology and pharmaceutical companies.
The company is headquartered in San Diego, California
